The DOI matches its Crossref record; 204 of the 204 references it cites were found in a registry or an index.
An excitatory synapse hypothesis of depression
Open accessAbstract
Depression is a common cause of mortality and morbidity, but the biological bases of the deficits in emotional and cognitive processing remain incompletely understood. Current antidepressant therapies are effective in only some patients and act slowly. Here, we propose an excitatory synapse hypothesis of depression in which chronic stress and genetic susceptibility cause changes in the strength of subsets of glutamatergic synapses at multiple locations, including the prefrontal cortex (PFC), hippocampus, and nucleus accumbens (NAc), leading to a dysfunction of corticomesolimbic reward circuitry that underlies many of the symptoms of depression. This hypothesis accounts for current depression treatments and suggests an updated framework for the development of better therapeutic compounds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It appears that increased strength of excitatory neurotransmission, in particular involving AMPARs, represents a common downstream target that is necessary for antidepressant efficacy among classical and rapid-acting antidepressants (Alt et al., 2006; Gould et al., 2019; Thompson et al., 2015).”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Thompson et al., 2015
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Collectively, these patterns observed in human patients are consistent with the premise that neuronal and molecular plasticity deficits may feed forward to impairments in the coordinated function of prefrontal and limbic regions 66 , resulting in impaired PFC regulation and unchecked stimulus-driven responses to salient negative stimuli.”
From Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model (2020) · cites this paper as [66]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although stress-induced structural changes in the PFC are equally important in their contribution to the pathophysiology of neuropsychiatric conditions [256–262]”
From Development of prefrontal cortex (2022) · cites this paper as [259]
Experimental — accuracy not yet measuredIn the citing paper
“Conventional antidepressant therapeutics including selective serotonin reuptake inhibitors (SSRIs) or non-typical therapeutics, including ketamine and brain stimulation, may alleviate depression symptoms by acting on excitatory brain systems (33).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [33]
In the citing paper
“Stress-induced dysfunction in forebrain excitatory transmission has led to the development of the excitatory synaptic transmission hypothesis of depression (22, 32, 33).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [33]
In the citing paper
“As glutamate clearance modulates neuronal excitability [200] and glutamatergic synapse strength contributes to depression [202], how astrocytic glutamate clearance contributes to excitatory synapse strength and subsequent depressive behavior is also worth further investigation in the reward circuit.”
From The molecular and cellular mechanisms of depression: a focus on reward circuitry (2019) · cites this paper as [202]
In the citing paper
“Indeed, a net result of all these processes is a sustained potentiation of excitatory synapses in cortico-mesolimbic brain circuits involved in the maintenance of mood and stress-reactivity 190.”
From Mechanisms of ketamine action as an antidepressant (2018) · cites this paper as [190]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,526
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
Deep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
The Neuroendocrinology of Stress: A Never Ending Story
Lightman, S. L. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01711.x · Cited by 3,588
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
Schildkraut, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,568
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
Cited by
Sorted by citations
Items 101–200 of 267
Kent, M., Bardi, M., Hazelgrove, A., Sewell, K., Kirk, E., Thompson, B., Trexler, K. R., Terhune‐Cotter, B., & Lambert, K. G. (2017) · Hormones and Behavior · doi:10.1016/j.yhbeh.2017.07.011 · Cited by 34
Barone, P. R. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000477 · Cited by 37
Wang, H., Liu, L., Rao, X., Zeng, B., Yu, Y., Zhou, C., Zeng, L., Zheng, P., Pu, J., Xu, S., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01024-9 · Cited by 34
A Double-Blind, Placebo-Controlled, Pilot Study of Riluzole Monotherapy for Acute Bipolar Depression
Park, L. T., Lener, M. S., Hopkins, M., Iadorola, N., Machado‐Vieira, R., Ballard, E. D., Nugent, A. C., & Zarate, C. A. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000693 · Cited by 34
Brain‐wide cellular mapping of acute stress‐induced activation in male and female mice
Kim, W., & Chung, C. (2021) · The FASEB Journal · doi:10.1096/fj.202101287r · Cited by 33
Chi, D.-M., Zhang, K., Zhang, J.-X., He, Z.-L., Zhou, H., Huang, W., Liu, Y., Huang, J., Zeng, W.-A., Bai, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57924-1 · Cited by 34
Kim, H. R., Lee, Y.-J., Kim, T.-W., Lim, R.-N., Hwang, D. Y., Moffat, J. J., Kim, S., Seo, J., & Ka, M. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-03121-0 · Cited by 36
Chen, Y., Zheng, Y., Yan, J., Zhu, C., Zeng, X., Zheng, S., Li, W., Yao, L., Xia, Y., Su, W.-W., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.720286 · Cited by 36
Wulff, A. B., Nichols, C. D., & Thompson, S. M. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109504 · Cited by 35
Self-citationKim, J., Joo, Y., Son, Y., Kim, J., Kim, Y.-K., Kim, H.-K., Lee, S., & Ido, T. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.12.001 · Cited by 32
Mei, L., Gao, Y., Chen, M., Zhang, X., Yue, W., Zhang, D., & Yu, H. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110450 · Cited by 33
Reply to: Antidepressant Actions of Ketamine Versus Hydroxynorketamine
Zanos, P., Moaddel, R., Morris, P. J., Wainer, I. W., Albuquerque, E. X., Thompson, S. M., Thomas, C. J., Zarate, C. A., & Gould, T. D. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.08.039 · Cited by 31
Self-citationTroppoli, T. A., Zanos, P., Georgiou, P., Gould, T. D., Rudolph, U., & Thompson, S. M. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.11.024 · Cited by 29
Self-citationPsychiatric Comorbidities of Inflammatory Bowel Disease: It Is a Matter of Microglia’s Gut Feeling
Fakhfouri, G., Mijailović, N. R., & Rahimian, R. (2024) · Cells · doi:10.3390/cells13020177 · Cited by 31
Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?
Carboni, E., Carta, A. R., Carboni, E., & Novelli, A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.657714 · Cited by 33
Liu, S., Abdellaoui, A., Verweij, K. J. H., & van Wingen, G. A. (2023) · Advanced Science · doi:10.1002/advs.202205486 · Cited by 28
Mao, Y., Fisher, D. W., Yang, S., Keszycki, R. M., & Dong, H. (2020) · PLOS ONE · doi:10.1371/journal.pone.0226021 · Cited by 28
Neuronal Plasticity: Neuronal Organization is Associated with Neurological Disorders
Dhuriya, Y. K., & Sharma, D. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01555-2 · Cited by 31
Román-Albasini, L., Díaz‐Véliz, G., Olave, F. A., Aguayo, F. I., García‐Rojo, G., Corrales, W. A., Silva, J. P., Avalos, A. M., Rojas, P. S., Aliaga, E., et al. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2020.100234 · Cited by 27
Li, G., Liu, Y., Zheng, Y., Wu, Y., Li, D., Liang, X., Chen, Y., Cui, Y., Yap, P., Qiu, S., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102758 · Cited by 27
Inflammation-activated C/EBPβ mediates high-fat diet-induced depression-like behaviors in mice
Li, Y., Chen, H., Wang, J., Wang, J., Niu, X., Wang, C., Qin, D., Li, F., Wang, Y., Xiong, J., et al. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1068164 · Cited by 27
Csabai, D., Seress, L., Varga, Z., Ábrahám, H., Miseta, A., Wiborg, O., & Czéh, B. (2016) · Hippocampus · doi:10.1002/hipo.22650 · Cited by 27
Novel Targets for Fast Antidepressant Responses: Possible Role of Endogenous Neuromodulators
Camargo, A., & Rodrigues, A. L. S. (2019) · Chronic Stress · doi:10.1177/2470547019858083 · Cited by 28
Kochanowska-Karamyan, A. J., ARAÚJO, H. C., Zhang, X., El‐Alfy, A. T., de Carvalho, P. B., Avery, M. A., Holmbo, S. D., Magolan, J., & Hamann, M. T. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.9b01107 · Cited by 27
A Role for Matrix Metalloproteases in Antidepressant Efficacy
Alaiyed, S., & Conant, K. E. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00117 · Cited by 26
Sex Differences in the Sustained Effects of Ketamine on Resilience to Chronic Stress
Okine, T., Shepard, R. M., Lemanski, E. A., & Coutellier, L. D. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.581360 · Cited by 26
Ciuculete, D. M., Voisin, S., Kular, L., Welihinda, N., Jonsson, J., Jagodic, M., Mwinyi, J., & Schiöth, H. (2019) · Epigenetics · doi:10.1080/15592294.2019.1700628 · Cited by 19
Targeting metabotropic glutamate receptors for rapid-acting antidepressant drug discovery
Musazzi, L. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1822814 · Cited by 26
Astrocytic GABAergic Regulation in Alcohol Use and Major Depressive Disorders
Ali, D. N., Ali, H. M., Lopez, M. R., Kang, S., & Choi, D. (2024) · Cells · doi:10.3390/cells13040318 · Cited by 26
Environmental control of microRNAs in the nervous system: Implications in plasticity and behavior
Codocedo, J. F., & Inestrosa, N. C. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.10.010 · Cited by 25
Dyke, A. M. V., Francis, T. C., Chen, H., Bailey, A. M., & Thompson, S. M. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.03.005 · Cited by 25
Self-citationRetractedMeng, P., Zhang, X., Liu, T., Liu, J., Luo, Y., Xie, M.-X., Yang, H., Fang, R. M., Guo, D., Zhong, Z., et al. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04000-0 · Cited by 26
Domin, H., Szewczyk, B., Pochwat, B., Woźniak, M., & Śmiałowska, M. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4495-3 · Cited by 25
Han, Y. S., Lyman, K. A., Foote, K. M., & Chetkovich, D. M. (2020) · Channels · doi:10.1080/19336950.2020.1740501 · Cited by 25
O’Neil, D. A., Nicholas, M. A., Lajud, N., Kline, A. E., & Bondi, C. O. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00579 · Cited by 25
The Engram’s Dark Horse: How Interneurons Regulate State-Dependent Memory Processing and Plasticity
Raven, F., & Aton, S. J. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.750541 · Cited by 29
Xue, S.-G., He, J., Lu, L.-L., Song, S.-J., Chen, M., Wang, F., & Chen, J. (2023) · Nature Communications · doi:10.1038/s41467-023-42780-8 · Cited by 24
Fucoidan exerts antidepressant-like effects in mice via regulating the stability of surface AMPARs
Li, M., Sun, X., Li, Q., Li, Y., Luo, C., Huang, H., Chen, J., Gong, C.-Z., Li, Y., Zheng, Y., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.10.043 · Cited by 23
Shisa6 mediates cell-type specific regulation of depression in the nucleus accumbens
Kim, H.-D., Wei, J., Call, T., Quintus, N. T., Summers, A. J., Carotenuto, S., Johnson, R., Ma, X., Xu, C., Park, J. G., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01217-8 · Cited by 24
Kawatake-Kuno, A., Murai, T., & Uchida, S. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.749180 · Cited by 26
Madur, L., Ineichen, C., Bergamini, G., Greter, A., Poggi, G., Cuomo-Haymour, N., Sigrist, H., Sych, Y., Paterna, J., Bornemann, K. D., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04811-4 · Cited by 24
Graves’ disease as a driver of depression: a mechanistic insight
Song, Y., Wang, X., Ma, W., Yang, Y., Yan, S., Sun, J., Zhu, X., & Tang, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1162445 · Cited by 26
Matrix metalloproteinase‐9: A magic drug target in neuropsychiatry?
Kaczmarek, K. T., Protokowicz, K., & Kaczmarek, L. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15976 · Cited by 23
Gattuso, J. J., Wilson, C., Hannan, A. J., & Renoir, T. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.16017 · Cited by 24
Toward a better understanding of the central consequences of intestinal inflammation
Nyuyki, K. D., & Pittman, Q. J. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12935 · Cited by 26
You, Y., Chen, Z., & Hu, W. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108606 · Cited by 25
Izumi, Y., Reiersen, A. M., Lenze, E. J., Mennerick, S. J., & Zorumski, C. F. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02343-3 · Cited by 22
Postsynaptic Proteins at Excitatory Synapses in the Brain—Relationship with Depressive Disorders
Samojedny, S., Czechowska, E., Pańczyszyn-Trzewik, P., & Sowa-Kućma, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911423 · Cited by 22
Kim, H., Wei, J., Call, T., Ma, X., Quintus, N. T., Summers, A. J., Carotenuto, S., Johnson, R., Nguyen, A., Cui, Y., et al. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.03.017 · Cited by 22
Protein kinase A mediates scopolamine-induced mTOR activation and an antidepressant response
Dong, J., Zhou, Q., Wei, Z., Yan, S. F., Sun, F., & Cai, X. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.11.041 · Cited by 21
Self-citationWidman, A. J., Cohen, J. L., McCoy, C. R., Unroe, K. A., Glover, M. E., Khan, A. U., Bredemann, T. M., McMahon, L. L., & Clinton, S. M. (2019) · Hippocampus · doi:10.1002/hipo.23092 · Cited by 21
Sakai, Y., Li, H., Inaba, H., Funayama, Y., Ishimori, E., Kawatake-Kuno, A., Yamagata, H., Seki, T., Hobara, T., Nakagawa, S., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102504 · Cited by 20
Yin, C., Huang, S.-Y., Gao, L., Lin, Y., Chang, L., Wu, H., Zhu, D., & Luo, C. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0422-20.2021 · Cited by 19
Impaired emotional response to stress in mice lacking galectin-1 or galectin-3
Sartim, A. G., Sartim, M. A., Cummings, R. D., Dias‐Baruffi, M., & Joca, S. R. L. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.112862 · Cited by 20
The role of GPR39 zinc receptor in the modulation of glutamatergic and GABAergic transmission
Starowicz, G., Siodłak, D., Nowak, G., & Młyniec, K. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00478-0 · Cited by 19
Hao, X., Zhu, X., Li, P., Lv, F., & Min, S. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.11.021 · Cited by 19
Maltbie, E. A., Gopinath, K., Urushino, N., Kempf, D., & Howell, L. L. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4175-8 · Cited by 18
Guo, F., Zhang, B., Fu, Z., Ma, Y., Gao, Y., Shen, F., Huang, C., & Li, Y. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.05.006 · Cited by 18
Lyman, K. A., Han, Y., Zhou, C., Renteria, I., Besing, G.-L., Kurz, J. E., & Chetkovich, D. M. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abl4580 · Cited by 17
Filippone, A., Cucinotta, L., Bova, V., Lanza, M., Casili, G., Paterniti, I., Campolo, M., Cuzzocrea, S., & Esposito, E. (2023) · Cells · doi:10.3390/cells12071040 · Cited by 18
Ramos‐Jiménez, A., Rubio-Valles, M., Ramos-Hernández, J. A., González-Rodríguez, E., & Moreno-Brito, V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178697 · Cited by 20
di Michele, F., Talamo, A., Niolu, C., & Siracusano, A. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200406090051 · Cited by 16
Role of group II metabotropic glutamate receptors in ketamine's antidepressant actions
Onisiforou, A., Georgiou, P., & Zanos, P. (2023) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2023.173531 · Cited by 12
Jiang, T., Feng, M., Hutsell, A., & Lüscher, B. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02835-8 · Cited by 14
Zhou, Q., Dong, J., Xu, T., & Cai, X. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.08.025 · Cited by 15
Self-citationRomán, C., Egert, L., & Benedetto, B. D. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14900 · Cited by 16
Riggs, L. M., Pereira, E. F. R., Thompson, S. M., & Gould, T. D. (2023) · Journal of Neurophysiology · doi:10.1152/jn.00326.2023 · Cited by 14
Self-citationSertraline modulates hippocampal plasticity via sigma 1 receptors, cellular stress and neurosteroids
Izumi, Y., Reiersen, A. M., Lenze, E. J., Mennerick, S. J., & Zorumski, C. F. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03185-3 · Cited by 14
Francis, T. C., & Porcu, A. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1188184 · Cited by 15
Yang, J., Ke, S., Qiao, Z., Yang, X., Qiu, X., Song, X., Zhao, E., Zhou, J., Zhao, M., Yang, Y., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.503477 · Cited by 14
León, B. E., Peyton, L., Essa, H., Wieden, T., Marion, N., Childers, W. E., Abou-Gharbia, M. A., & Choi, D. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109515 · Cited by 12
Qin, X., Fang, H., Shan, Q., Qi, C., & Zhou, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082677 · Cited by 14
Updates in the neuroendocrinology of stress and its clinical management
Quijije, N. V. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000176 · Cited by 12
Joffe, M. E., Santiago, C. I., Vermudez, S. A. D., Fisher, N. M., Dogra, S., Niswender, C. M., & Conn, P. J. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01041-2 · Cited by 12
The pattern glare and visual memory are disrupted in patients with major depressive disorder
Wang, M., Qi, X., Yang, X., Fan, H., Dou, Y., Guo, W., Wang, Q., Chen, E. Y. H., Li, T., & Ma, X. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04167-9 · Cited by 11
Emerging role of synaptic actin-regulatory pathway in the pathophysiology of mood disorders
Choi, S., & Han, K. (2015) · Animal Cells and Systems · doi:10.1080/19768354.2015.1086435 · Cited by 12
Neuroplasticity pathways and protein-interaction networks are modulated by vortioxetine in rodents
Waller, J. A., Nygaard, S. H., Li, Y., du Jardin, K. G., Tamm, J. A., Abdourahman, A., Elfving, B., Pehrson, A. L., Sánchez, C., & Wernersson, R. (2017) · BMC Neuroscience · doi:10.1186/s12868-017-0376-x · Cited by 11
Jiang, L., Zhang, H., He, Y., Liu, H., Li, S., Chen, R., Han, S., Zhou, Y., Zhang, J., Wan, X., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109076 · Cited by 11
He, J., Han, D., Jia, C., Xie, J., Zhu, F., Wei, J., Li, D., Wei, D., Li, Y., Li, T., et al. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s399183 · Cited by 11
Anhedonia and the Relationship Between Other Depressive Symptoms and Aggressive Behavior
Salem, T., Winer, E. S., Jordan, D. G., Nadorff, M. R., Fanning, J. R., Bryant, J. S., Berman, M. E., & Veilleux, J. C. (2018) · Journal of Interpersonal Violence · doi:10.1177/0886260518770646 · Cited by 10
Yin, M.-Y., Guo, L., Zhao, L., Zhang, C., Liu, W.-P., Zhang, C.-Y., Huo, J.-H., Wang, L., Li, S., Zheng, C., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-02945-0 · Cited by 10
Bączyńska, E., Zaręba-Kozioł, M., Ruszczycki, B., Krzystyniak, A., Wójtowicz, T., Bijata, K., Pochwat, B., Magnowska, M., Roszkowska, M., Figiel, I., et al. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100683 · Cited by 10
Soto, N. N., Gaspar, P., & Bacci, A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00828 · Cited by 8
Roles of AMPA receptors in social behaviors
Xu, Q. W., Larosa, A., & Wong, T. P. (2024) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2024.1405510 · Cited by 6
Shao, M., Botvinov, J., Banerjee, D., Girirajan, S., & Lüscher, B. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02832-x · Cited by 9
Xu, Y., Wang, M., Wei, H., Yu, M., & Li, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113946 · Cited by 8
Li, X., Rao, Y., Li, G., He, L., Wang, Y., He, W., Fang, P., Pei, C., 堂西, 倫., Xie, H., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-92030-8 · Cited by 9
Hippocampal Zkscan4 confers resilience to chronic stress–induced depression-like behaviors
Gao, K., Yang, Y., Sun, X., Wang, J., Sun, X., Lu, T., Wang, L., Li, M., Yue, W., Liu, H., et al. (2025) · Science Advances · doi:10.1126/sciadv.adr2291 · Cited by 8
Ma, G., Wu, J., Wu, Y., Yang, J., Zhang, J., Huang, Y., Tian, R., Zhou, X., Tan, X., Li, Y., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03088-9 · Cited by 9
Deng, Q., Zhang, S.-Q., Yang, P., Dong, W., Wang, F., Long, L., & Chen, J. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01074-x · Cited by 7
Ingestion of Gouda Cheese Ameliorates the Chronic Unpredictable Mild Stress in Mice
Yun, B., Yoo, J., Park, M., Ryu, S., Lee, W. J., Choi, H., Kang, M. K., Kim, Y., & Oh, S. (2019) · Food Science of Animal Resources · doi:10.5851/kosfa.2019.e81 · Cited by 8
Light-dependent effects on mood: Mechanistic insights from animal models
Copenhaver, A. E., Roberts, R. C., & LeGates, T. A. (2022) · Progress in brain research · doi:10.1016/bs.pbr.2022.02.016 · Cited by 8
Self-citationThe Role of the Glutamate System in Posttraumatic Stress Disorder and Glutamate-Based Treatments
Popoli, M., Ieraci, A., & Musazzi, L. (2022) · Springer eBooks · doi:10.1007/978-3-030-87480-3_5 · Cited by 8
Discovery of a small-molecule inhibitor of the TRIP8b–HCN interaction with efficacy in neurons
Han, Y. S., Iyamu, I. D., Clutter, M. R., Mishra, R. K., Lyman, K. A., Zhou, C., Michailidis, I. E., Xia, M. Y., Sharma, H., Luan, C.-H., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102069 · Cited by 9
Peri-Ictal Changes in Depression and Anxiety in Persons With Epileptic and Non-epileptic Seizures
Hopp, J. L., Pahlavan, A., Richert, M. E., Grimes, K., Turlington, K., Cassady, M. K., Kvarta, M. D., & Thompson, S. M. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.912697 · Cited by 10
Self-citationDeng, Q., Zhang, S.-Q., Yang, P., Dong, W., Wang, J., Chen, J., Wang, F., & Long, L. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14046 · Cited by 7
Somatostatin-positive GABAergic interneuron: new targets for depression
Zhang, C., Liu, X., & Yuan, T.-F. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.11 · Cited by 8
Carboni, L., Nguyen, T., & Caberlotto, L. (2016) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201500149 · Cited by 7
Maia, M. A., Jurcevic, J. D., Malheiros, Â., Cazarin, C. A., Dalmagro, A. P., Santo, C. D. E., da Silva, L. M., & de Souza, M. M. (2023) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2023/1183809 · Cited by 6
Zhu, J., Guo, S., Hu, S., & Chen, Q. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114440 · Cited by 6
Metadata
- Authors
- Thompson, S. M., Kallarackal, A. J., Kvarta, M. D., Van Dyke, A. M., LeGates, T. A., & Cai, X.
- Affiliations
- University of Maryland, Baltimore (US)
- Southern Illinois University Carbondale (US)
- Corresponding author
- Thompson, Scott M.
- Venue
- Trends in Neurosciences
- Publisher
- Elsevier BV
- Published
- 2015-05
- Volume
- 38
- Issue
- 5
- Pages
- 279-294
- ISSN
- 0166-2236 (ISSN-L)
- PMC
- PMC4417609
- OpenAlex
- W2088861514
- Cited by
- 265
- References
- 203
- Citations by year
- 2026: 5 · 2025: 17 · 2024: 23 · 2023: 34 · 2022: 23 · 2021: 33 · 2020: 29 · 2019: 28 · 2018: 20 · 2017: 22 · 2016: 17 · 2015: 14
- FWCI
- 3.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Trends in Neurosciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (2t32ns063391-21)
- National Institute of Mental Health (R01MH086828)
- National Institute of General Medical Sciences (T32GM008181, T32GM092237)
- National Institute of Neurological Disorders and Stroke (T32NS007375, T32-NS063391)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- depression, glutamatergic synapses, chronic stress, genetic susceptibility, prefrontal cortex, hippocampus, nucleus accumbens, antidepressant treatment, synaptic plasticity
- MeSH terms
- Animals, Antidepressive Agents, Brain, Depression, Humans, Synapses, Excitatory Postsynaptic Potentials
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review